While in middle stage LSCC, MMP2 is upregulated by the regulation of TF JunB in the aberrance of miR-106b and is also affected by DNA methylation, suggesting that the dysfunction of miR-106b can cause the abnormal ECM degradation to potentially promote the invasion and metastasis of cancer cells. This evidence concerns the gene MMP2 and cancer.